ethinyl estradiol
No data available for drug.
DRUG INTERACTION
No drug interaction found for ethinyl estradiol and .
pegaspargase
They may increase the thrombogenic effect when combined with asparaginase Products
prednisolone
may diminish the concentration of serum when combined with hormonal contraceptives
propofol
may diminish the concentration of serum when combined with hormonal contraceptives
phenobarbital
may decrease the levels of serum concentration of hormonal contraceptives
isoniazid
may decrease the levels of serum concentration of hormonal contraceptives
propofol
may decrease the levels of serum concentration of hormonal contraceptives
selexipag
may decrease the levels of serum concentration of hormonal contraceptives
carbamazepine
may decrease the levels of serum concentration of hormonal contraceptives
amprenavir
may decrease the levels of serum concentration of hormonal contraceptives
fostemsavir
may decrease the levels of serum concentration of hormonal contraceptives
indinavir
may decrease the levels of serum concentration of hormonal contraceptives
tirzepatide
may reduce the levels of serum concentration of hormonal contraceptives
aprepitant
aprepitant: they may diminish the serum concentration of hormonal contraceptives
asunaprevir
asunaprevir: they may diminish the serum concentration of hormonal contraceptives
atazanavir
atazanavir: they may diminish the serum concentration of hormonal contraceptives
brigatinib
brigatinib: they may diminish the serum concentration of hormonal contraceptives
carfilzomib
carfilzomib: they may increase the thrombogenic effect of hormonal contraceptives
cladribine
cladribine: they may decrease the therapeutic effect of hormonal contraceptives
cobicistat
cobicistat: they may diminish the serum concentration of hormonal contraceptives
efavirenz
efavirenz: they may diminish the serum concentration of hormonal contraceptives
elagolix
elagolix: they may diminish the therapeutic effect of hormonal contraceptives
exenatide
exenatide: they may diminish the therapeutic effect of hormonal contraceptives
felbamate
felbamate: they may diminish the serum concentration of hormonal contraceptives
fosaprepitant
fosaprepitant: they may diminish the serum concentration of hormonal contraceptives
griseofulvin
griseofulvin: they may diminish the serum concentration of hormonal contraceptives
ivosidenib
ivosidenib: they may diminish the serum concentration of hormonal contraceptives
ixazomib
ixazomib: they may diminish the serum concentration of hormonal contraceptives
lixisenatide
lixisenatide: they may decrease the therapeutic effect of hormonal contraceptives
mavacamten
mavacamten: they may diminish the serum concentration of hormonal contraceptives
mifepristone
mifepristone: they may decrease the therapeutic effect of hormonal contraceptives
mycophenolate mofetil
mycophenolate mofetil: they may diminish the serum concentration of hormonal contraceptives
nirmatrelvir/ritonavir
nirmatrelvir and ritonavir: they may diminish the serum concentration of hormonal contraceptives
oxcarbazepine
oxcarbazepine: they may diminish the serum concentration of hormonal contraceptives
pitolisant
pitolisant: they may diminish the serum concentration of hormonal contraceptives
nelfinavir
protease inhibitors: they may diminish the serum concentration of hormonal contraceptives
tazemetostat
tazemetostat: they may diminish the serum concentration of hormonal contraceptives
cannabidiol
cannabidiol: they may diminish the serum concentration of hormonal contraceptives
sotorasib
may diminish the serum concentration of CYP3A4 Inducers
etonogestrel
may diminish the serum concentration of each other when combined
sugammadex
may decrease the therapeutic effect of each other when combined
prednisolone
may diminish the concentration of serum when combined with hormonal contraceptives
encorafenib
encorafenib: they may diminish the serum concentration of hormonal contraceptives
mobocertinib
mobocertinib: they may diminish the serum concentration of hormonal contraceptives
omaveloxolone
omaveloxolone: they may diminish the serum concentration of hormonal contraceptives
pexidartinib
pexidartinib: they may diminish the serum cocentration of hormonal contraceptives
tranexamic acid
tranexamic acid: they may increase the thrombogenic effect of hormonal contraceptives
acenocoumarol
may increase the serum concentration of Vitamin K Antagonists
fluindione
may increase the serum concentration of Vitamin K Antagonists
phenindione
may increase the serum concentration of Vitamin K Antagonists
phylloquinone
may increase the serum concentration of Vitamin K Antagonists
warfarin
may increase the serum concentration of Vitamin K Antagonists
acenocoumarol
may increase the levels of serum concentration of vitamin K antagonists
fluindione
may increase the levels of serum concentration of vitamin K antagonists
phenindione
may increase the levels of serum concentration of vitamin K antagonists
phylloquinone
may increase the levels of serum concentration of vitamin K antagonists
warfarin
may increase the levels of serum concentration of vitamin K antagonists
lenacapavir
may increase the levels of serum concentration
abiraterone
may increase the levels of serum concentration
mibefradil
may increase the levels of serum concentration
citalopram
may increase the levels of serum concentration
efavirenz
may increase the levels of serum concentration
maralixibat
may increase the levels of serum concentration
lenacapavir
may increase the levels of serum concentration
curcumin
may increase the levels of serum concentration
glecaprevir
may increase the levels of serum concentration
caspofungin
may increase the levels of serum concentration
maralixibat
may increase the levels of serum concentration
lenacapavir
may increase the levels of serum concentration
diacerein
may increase the levels of serum concentration
bacampicillin
When bacampicillin combines with ethinyl estradiol the effect and action of ethinyl estradiol decreases.
penicillin G benzathine
When penicillin G benzathine combines with ethinyl estradiol, the effect and activity of ethinyl estradiol decreases.
cefprozil
cefprozil will reduce the therapeutic effects of oral forms of hormones by altering gut microflora
cefaclor
cefaclor will reduce the therapeutic effects of oral forms of hormones by altering gut microflora
cefepime
cefepime will reduce the therapeutic effects of oral forms of hormones by altering gut microflora
cefuroxime
cefuroxime will reduce the therapeutic effects of oral forms of hormones by altering gut microflora
carfilzomib
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
ritonavir
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
simeprevir
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
bortezomib
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
fosamprenavir
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
efavirenz
CYP3A4 Inducers may decrease the levels of serum concentration of hormonal contraceptives
diacerein
may decrease the levels of serum concentration of hormonal contraceptives
tranylcypromine
may decrease the levels of serum concentration of hormonal contraceptives
anastrozole
may decrease the levels of serum concentration of hormonal contraceptives
lenacapavir
may increase the levels of serum concentration of hormonal contraceptives
abiraterone
may increase the levels of serum concentration of hormonal contraceptives
mibefradil
may increase the levels of serum concentration of hormonal contraceptives
isoniazid
may increase the levels of serum concentration of hormonal contraceptives
mexiletine
may increase the levels of serum concentration of hormonal contraceptives
lenacapavir
may increase the levels of serum concentration of hormonal contraceptives
curcumin
may increase the levels of serum concentration of hormonal contraceptives
glecaprevir
may increase the levels of serum concentration of hormonal contraceptives
caspofungin
may increase the levels of serum concentration of hormonal contraceptives
abiraterone
may increase the levels of serum concentration of hormonal contraceptives
primidone
may decrease the levels of serum concentration
citalopram
may increase the levels of serum concentration
efavirenz
may increase the levels of serum concentration
maralixibat
may decrease the levels of serum concentration
maralixibat
may increase the levels of serum concentration
lenacapavir
may increase the levels of serum concentration
etravirine
etravirine: they may diminish the serum concentration of hormonal contraceptive
flibanserin
flibanserin: they may enhance the serum concentration of hormonal contraceptives
thalidomide
thalidomide: they may increase the thrombogenic effect of hormonal contraceptives
voriconazole
voriconazole: they may enhance the serum concentration of hormonal contraceptives
ergonovine
It may enhance the risk of adverse reactions when combined with Ergot alkaloids
cabergoline
It may enhance the risk of adverse reactions when combined with Ergot alkaloids
dihydroergocornine
It may enhance the risk of adverse reactions when combined with Ergot alkaloids
dihydroergocristine
It may enhance the risk of adverse reactions when combined with Ergot alkaloids
dihydroergotamine
It may enhance the risk of adverse reactions when combined with Ergot alkaloids
primidone
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
phenobarbital
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
carbamazepine
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
efavirenz
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
isoniazid
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
topiramate
topiramate decreases the concentration of hormonal contraceptives in the serum
perampanel
perampanel decreases the concentration of hormonal contraceptives in the serum
mycophenolate
mycophenolate could potentially lead to a reduction in the concentration serum of hormonal contraceptives
ethinyl estradiol
No data available for drug.
DRUG INTERACTION
ethinyl estradiol
&
No Drug Intearction Found. for ethinyl estradiol and .
pegaspargase
They may increase the thrombogenic effect when combined with asparaginase Products
prednisolone
may diminish the concentration of serum when combined with hormonal contraceptives
propofol
may diminish the concentration of serum when combined with hormonal contraceptives
phenobarbital
may decrease the levels of serum concentration of hormonal contraceptives
isoniazid
may decrease the levels of serum concentration of hormonal contraceptives
propofol
may decrease the levels of serum concentration of hormonal contraceptives
selexipag
may decrease the levels of serum concentration of hormonal contraceptives
carbamazepine
may decrease the levels of serum concentration of hormonal contraceptives
amprenavir
may decrease the levels of serum concentration of hormonal contraceptives
fostemsavir
may decrease the levels of serum concentration of hormonal contraceptives
indinavir
may decrease the levels of serum concentration of hormonal contraceptives
tirzepatide
may reduce the levels of serum concentration of hormonal contraceptives
aprepitant
aprepitant: they may diminish the serum concentration of hormonal contraceptives
asunaprevir
asunaprevir: they may diminish the serum concentration of hormonal contraceptives
atazanavir
atazanavir: they may diminish the serum concentration of hormonal contraceptives
brigatinib
brigatinib: they may diminish the serum concentration of hormonal contraceptives
carfilzomib
carfilzomib: they may increase the thrombogenic effect of hormonal contraceptives
cladribine
cladribine: they may decrease the therapeutic effect of hormonal contraceptives
cobicistat
cobicistat: they may diminish the serum concentration of hormonal contraceptives
efavirenz
efavirenz: they may diminish the serum concentration of hormonal contraceptives
elagolix
elagolix: they may diminish the therapeutic effect of hormonal contraceptives
exenatide
exenatide: they may diminish the therapeutic effect of hormonal contraceptives
felbamate
felbamate: they may diminish the serum concentration of hormonal contraceptives
fosaprepitant
fosaprepitant: they may diminish the serum concentration of hormonal contraceptives
griseofulvin
griseofulvin: they may diminish the serum concentration of hormonal contraceptives
ivosidenib
ivosidenib: they may diminish the serum concentration of hormonal contraceptives
ixazomib
ixazomib: they may diminish the serum concentration of hormonal contraceptives
lixisenatide
lixisenatide: they may decrease the therapeutic effect of hormonal contraceptives
mavacamten
mavacamten: they may diminish the serum concentration of hormonal contraceptives
mifepristone
mifepristone: they may decrease the therapeutic effect of hormonal contraceptives
mycophenolate mofetil
mycophenolate mofetil: they may diminish the serum concentration of hormonal contraceptives
nirmatrelvir/ritonavir
nirmatrelvir and ritonavir: they may diminish the serum concentration of hormonal contraceptives
oxcarbazepine
oxcarbazepine: they may diminish the serum concentration of hormonal contraceptives
pitolisant
pitolisant: they may diminish the serum concentration of hormonal contraceptives
nelfinavir
protease inhibitors: they may diminish the serum concentration of hormonal contraceptives
tazemetostat
tazemetostat: they may diminish the serum concentration of hormonal contraceptives
cannabidiol
cannabidiol: they may diminish the serum concentration of hormonal contraceptives
sotorasib
may diminish the serum concentration of CYP3A4 Inducers
etonogestrel
may diminish the serum concentration of each other when combined
sugammadex
may decrease the therapeutic effect of each other when combined
prednisolone
may diminish the concentration of serum when combined with hormonal contraceptives
encorafenib
encorafenib: they may diminish the serum concentration of hormonal contraceptives
mobocertinib
mobocertinib: they may diminish the serum concentration of hormonal contraceptives
omaveloxolone
omaveloxolone: they may diminish the serum concentration of hormonal contraceptives
pexidartinib
pexidartinib: they may diminish the serum cocentration of hormonal contraceptives
tranexamic acid
tranexamic acid: they may increase the thrombogenic effect of hormonal contraceptives
acenocoumarol
may increase the serum concentration of Vitamin K Antagonists
fluindione
may increase the serum concentration of Vitamin K Antagonists
phenindione
may increase the serum concentration of Vitamin K Antagonists
phylloquinone
may increase the serum concentration of Vitamin K Antagonists
warfarin
may increase the serum concentration of Vitamin K Antagonists
acenocoumarol
may increase the levels of serum concentration of vitamin K antagonists
fluindione
may increase the levels of serum concentration of vitamin K antagonists
phenindione
may increase the levels of serum concentration of vitamin K antagonists
phylloquinone
may increase the levels of serum concentration of vitamin K antagonists
warfarin
may increase the levels of serum concentration of vitamin K antagonists
lenacapavir
may increase the levels of serum concentration
abiraterone
may increase the levels of serum concentration
mibefradil
may increase the levels of serum concentration
citalopram
may increase the levels of serum concentration
efavirenz
may increase the levels of serum concentration
maralixibat
may increase the levels of serum concentration
lenacapavir
may increase the levels of serum concentration
curcumin
may increase the levels of serum concentration
glecaprevir
may increase the levels of serum concentration
caspofungin
may increase the levels of serum concentration
maralixibat
may increase the levels of serum concentration
lenacapavir
may increase the levels of serum concentration
diacerein
may increase the levels of serum concentration
bacampicillin
When bacampicillin combines with ethinyl estradiol the effect and action of ethinyl estradiol decreases.
penicillin G benzathine
When penicillin G benzathine combines with ethinyl estradiol, the effect and activity of ethinyl estradiol decreases.
cefprozil
cefprozil will reduce the therapeutic effects of oral forms of hormones by altering gut microflora
cefaclor
cefaclor will reduce the therapeutic effects of oral forms of hormones by altering gut microflora
cefepime
cefepime will reduce the therapeutic effects of oral forms of hormones by altering gut microflora
cefuroxime
cefuroxime will reduce the therapeutic effects of oral forms of hormones by altering gut microflora
carfilzomib
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
ritonavir
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
simeprevir
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
bortezomib
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
fosamprenavir
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
efavirenz
CYP3A4 Inducers may decrease the levels of serum concentration of hormonal contraceptives
diacerein
may decrease the levels of serum concentration of hormonal contraceptives
tranylcypromine
may decrease the levels of serum concentration of hormonal contraceptives
anastrozole
may decrease the levels of serum concentration of hormonal contraceptives
lenacapavir
may increase the levels of serum concentration of hormonal contraceptives
abiraterone
may increase the levels of serum concentration of hormonal contraceptives
mibefradil
may increase the levels of serum concentration of hormonal contraceptives
isoniazid
may increase the levels of serum concentration of hormonal contraceptives
mexiletine
may increase the levels of serum concentration of hormonal contraceptives
lenacapavir
may increase the levels of serum concentration of hormonal contraceptives
curcumin
may increase the levels of serum concentration of hormonal contraceptives
glecaprevir
may increase the levels of serum concentration of hormonal contraceptives
caspofungin
may increase the levels of serum concentration of hormonal contraceptives
abiraterone
may increase the levels of serum concentration of hormonal contraceptives
primidone
may decrease the levels of serum concentration
citalopram
may increase the levels of serum concentration
efavirenz
may increase the levels of serum concentration
maralixibat
may decrease the levels of serum concentration
maralixibat
may increase the levels of serum concentration
lenacapavir
may increase the levels of serum concentration
etravirine
etravirine: they may diminish the serum concentration of hormonal contraceptive
flibanserin
flibanserin: they may enhance the serum concentration of hormonal contraceptives
thalidomide
thalidomide: they may increase the thrombogenic effect of hormonal contraceptives
voriconazole
voriconazole: they may enhance the serum concentration of hormonal contraceptives
ergonovine
It may enhance the risk of adverse reactions when combined with Ergot alkaloids
cabergoline
It may enhance the risk of adverse reactions when combined with Ergot alkaloids
dihydroergocornine
It may enhance the risk of adverse reactions when combined with Ergot alkaloids
dihydroergocristine
It may enhance the risk of adverse reactions when combined with Ergot alkaloids
dihydroergotamine
It may enhance the risk of adverse reactions when combined with Ergot alkaloids
primidone
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
phenobarbital
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
carbamazepine
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
efavirenz
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
isoniazid
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
topiramate
topiramate decreases the concentration of hormonal contraceptives in the serum
perampanel
perampanel decreases the concentration of hormonal contraceptives in the serum
mycophenolate
mycophenolate could potentially lead to a reduction in the concentration serum of hormonal contraceptives
medtigo
ethinyl estradiol